myocardial-infarction-percutaneous-embolization-coil-deployment-swine

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model

Myocardial infarction (MI) is the leading cause of mortality worldwide. Despite the use of evidence-based treatments, including coronary revascularization ...

Germans Trias i Pujol University Hospital

Growth differentiation factor 15 (GDF-15) is an inflammatory cytokine released in response to tissue injury. It has prognostic value in cardiovascular diseases and other acute and chronic conditions. Here, we explored the value of GDF-15 as an early predictor of neurologic outcome after an out-of-hospital cardiac arrest (OHCA).

Growth differentiation factor 15 and early prognosis after out-of-hospital cardiac arrest.

Up to one-third of patients who undergo cardiac resynchronization therapy do not obtain clinical benefit. A systematic approach can identify treatable causes in many nonresponding patients. We present a case of nonresponse to cardiac resynchronization therapy that resolved by ablation of the atrioventricular node in a patient with complete atrioventricular block. ().

Julia Aranyo

Heart Institute (iCOR)

Germans Trias i Pujol University Hospital

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model

Julia Aranyo

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Heart Institute (iCOR)

Germans Trias i Pujol University Hospital

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model

Heart Institute (iCOR)